Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$80.83 USD
-7.08 (-8.05%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $80.63 -0.20 (-0.25%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $1.10 | 0.00% |
Earnings Summary
For their last quarter, Ligand Pharmaceuticals (LGND) reported earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.13 per share. This reflects a positive earnings surprise of 6.19%. Look out for LGND's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $1.10 per share, reflecting a year-over-year decrease of 22.54%.
Earnings History
Price & Consensus
Zacks News for LGND
Recent Price Trend in Ligand (LGND) is Your Friend, Here's Why
LGND: What are Zacks experts saying now?
Zacks Private Portfolio Services